Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katia Mellal

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers of Hormone Research|June 20, 2014
Potential peptides in atherosclerosis therapySylvie Marleau, Katia Mellal, David N Huynh, et al.
Atherosclerosis|July 25, 2013
EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient miceKim Bujold, Katia Mellal, Karina F Zoccal, et al.
Development (Cambridge, England)|December 5, 2024
Molecular characterization and sub-retinal transplantation of hypoimmunogenic human retinal sheets in a minipig model of severe photoreceptor degenerationAndrea Barabino, Katia Mellal, Rimi Hamam, et al.
Biomedicines|October 27, 2018
Azasulfurylpeptide Modulation of CD36-Mediated Inflammation Without Effect on NeovascularizationStéphane Turcotte, Katia Mellal, Ramesh Chingle, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2012
Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient miceVíctor Brito, Katia Mellal, Simon Giroux Portelance, et al.
Frontiers in Pharmacology|November 23, 2017
Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient MiceVictor Brito, Katia Mellal, Karina F Zoccal, et al.
Atherosclerosis|July 30, 2020
Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient miceGeneviève Frégeau, Roger Sarduy, Hanan Elimam, et al.
Scientific Reports|September 11, 2019
Immunometabolic modulation of retinal inflammation by CD36 ligandKatia Mellal, Samy Omri, Mukandila Mulumba, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers of Hormone Research|June 20, 2014
Potential peptides in atherosclerosis therapySylvie Marleau, Katia Mellal, David N Huynh, et al.
Atherosclerosis|July 25, 2013
EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient miceKim Bujold, Katia Mellal, Karina F Zoccal, et al.
Development (Cambridge, England)|December 5, 2024
Molecular characterization and sub-retinal transplantation of hypoimmunogenic human retinal sheets in a minipig model of severe photoreceptor degenerationAndrea Barabino, Katia Mellal, Rimi Hamam, et al.
Biomedicines|October 27, 2018
Azasulfurylpeptide Modulation of CD36-Mediated Inflammation Without Effect on NeovascularizationStéphane Turcotte, Katia Mellal, Ramesh Chingle, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2012
Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient miceVíctor Brito, Katia Mellal, Simon Giroux Portelance, et al.
Frontiers in Pharmacology|November 23, 2017
Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient MiceVictor Brito, Katia Mellal, Karina F Zoccal, et al.
Atherosclerosis|July 30, 2020
Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient miceGeneviève Frégeau, Roger Sarduy, Hanan Elimam, et al.
Scientific Reports|September 11, 2019
Immunometabolic modulation of retinal inflammation by CD36 ligandKatia Mellal, Samy Omri, Mukandila Mulumba, et al.
Pageof 1